Results 51 to 60 of about 12,403 (234)

ANCA-associated vasculitis – Should we change the standard of care? [PDF]

, 2015
Collaborative clinical trials over the last 25 years have revolutionised the care of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This has led to production of management recommendations and standards of care.
Bligny, Bourgarit, Choi, de Groot, De Groot, Fauci, Faurschou, Finkielman, Flossmann, Ghosh, Guillevin, Han, Harper, Hauer, Hoffman, Jayne, Jennette, Jennette, Koldingsnes, Leavitt, Luqmani, Mahr, Masi, Mooney, Mooney, Mukhtyar, Mukhtyar, Mukhtyar, Mukhtyar, Nataraja, Ntatsaki, Pagnoux, Pradhan, Rahmattulla, Rao, Reinhold-Keller, Sharma, Sorensen, Stone, Stone, Suppiah, Talar-Williams, Walsh, Watts, Watts, Watts   +45 more
core   +1 more source

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype

ACR Open Rheumatology, 2023
To evaluate mepolizumab's efficacy in eosinophilic granulomatosis with polyangiitis (EGPA) with and without a vasculitic phenotype.
B. Terrier, D. Jayne, B. Hellmich, J. Bentley, J. Steinfeld, S. Yancey, N. Kwon, P. Akuthota, P. Khoury, L. Baylis, M. Wechsler   +10 more
semanticscholar   +1 more source

Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 75 dogs (2006-2016). [PDF]

, 2019
BackgroundEosinophilic lung disease is a poorly understood inflammatory airway disease that results in substantial morbidity.ObjectiveTo describe clinical findings in dogs with eosinophilic lung disease defined on the basis of radiographic, bronchoscopic,
Dear, Jonathan D, Hulsebosch, Sean E, Johnson, Eric G, Johnson, Lynelle R, Vernau, William   +4 more
core   +1 more source

Cutaneous Vasculitis as Early Presentation of Eosinophilic Granulomatosis with Polyangiitis without Systemic Symptoms

Oman Medical Journal, 2019
Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) is a rare vasculitis in children. It commonly presents with respiratory symptoms, especially asthma, allergic rhinitis, and peripheral eosinophilia.
Wahinuddin Sulaiman, Aris Chandran Abdullah, Sin Fah Chung, Norain Karim, Jyi Jong Tang   +4 more
doaj   +1 more source

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis

BMC Pulmonary Medicine, 2018
Background Granulomatosis with polyangiitis (GPA) is a systemic ANCA-associated vasculitis characterized by necrotizing granulomatous inflammation and a predilection for the upper and lower respiratory tract. Eosinophilic granulomatosis with polyangiitis
Michele V. Quan, Stephen K. Frankel, Mehrnaz Maleki-Fischbach, Laren D. Tan   +3 more
doaj   +1 more source

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV

RMD Open, 2023
Objective To summarise and update evidence to inform the 2022 update of the European Alliance of Associations of Rheumatology (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
B. Sánchez-Álamo, J. Schirmer, B. Hellmich, D. Jayne, S. Monti, G. Tómasson, R. Luqmani   +6 more
semanticscholar   +1 more source

Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis [PDF]

, 2016
Background Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a small- and medium-sized vasculitis classically seen in adult patients, with peak onset near the fifth to seventh decade of life.
Andreoli, Sharon P., Kouri, Anne M.
core   +1 more source

THE 2015 INTERNATIONAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS

Научно-практическая ревматология, 2016
In 2015, guidelines for the diagnosis and treatment of eosinophilic granulomatosis with polyangiitis, formerly known as Churg-Strauss syndrome, were prepared with the participation of experts from 5 countries of Europe, the USA, and Canada, who ...
T. V. Beketova, M. Yu. Volkov
doaj   +1 more source

Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis (EGPA) in Japan: 48-week interim analysis of the MARS study.

Modern Rheumatology, 2023
OBJECTIVES : Assess real-world, long-term safety/effectiveness of mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA) in Japan. METHODS : MARS (GSK ID:213684/NCT04551989) is an ongoing 96-week study of patients with EGPA who received 4-
Tomonori Ishii, H. Kunishige, Tamami Kobayashi, E. Hayashi, Masaki Komatsubara, Takeo Ishii, R. Alfonso-Cristancho, J. Tamaoki, P. Howarth   +8 more
semanticscholar   +1 more source

Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. [PDF]

, 2014
Exposure to levamisole-adulterated cocaine can induce a distinct clinical syndrome characterized by retiform purpura and/or agranulocytosis accompanied by an unusual constellation of serologic abnormalities including antiphospholipid antibodies, lupus ...
Butcher, Brad, Carlson, Adam Q, Graf, Jonathan, Imboden, John B, Jen, Kuang-Yu, Sam, Ramin, Tuot, Delphine S   +6 more
core   +2 more sources